The influence of Rhodiola rosea extracts and rosavin on cutaneous angiogenesis induced in mice after grafting of syngeneic tumor cells

Central-European Journal of Immunology

Volumn 33, Issue 3, 2008, Pages 102-107

  Skopińska Rózewska, Ewa ^a,e   Hartwich, Małgorzata ^f   Siwicki, Andrzej K ^b   Wasiutyński, Aleksander ^a   Sommer, Ewa ^a   Mazurkiewicz, Michał ^a   Bany, Janusz ^c   Skurzak, Henryk ^d  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^c MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

^d INSTITUTE OF ONCOLOGY   (Poland)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

^f NONE

Author keywords

Angiogenesis; L 1 sarcoma; Mice; Rhodiola rosea; Rosavin; Tumor cells

Indexed keywords

ANGIOGENESIS INHIBITOR; RHODIOLA ROSEA EXTRACT; ROSAVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CONTROLLED STUDY; DRUG ISOLATION; FEMALE; MOUSE; NONHUMAN; PLANT ROOT; RHIZOME; RHODIOLA; SARCOMA; SARCOMA CELL; SKIN SARCOMA; STRUCTURE ACTIVITY RELATION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 44449174526     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Monograph Rhodiola rosea (2002): Altern Med Rev 7: 421-423.
2. Kurkin VA, Dubishchev AV, Ezhkov VH et al. (2007): Nootropic activity of some phytopreparations and phenylpropanoids. Rastitel'nye Resur 43: 76-88.
3. Goldstein M S, Chen CW, Mammone T, Gan DC (2006): Cosmetic compositions comprising UV-protective rosavin. US Pat Appl Publ. 8.
4. Panossian A, Wagner H (2005): Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytother Res 19: 819-838.
5. Ming DS, Hillhouse BJ, Guns ES et al. (2005): Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res 19: 740-743.
6. Yaremrnii IN, Grigor'eva NF (2002): Hepatoprotector properties of liquid extract from Rhodiola rosea. Eksperimental'naya i Klinicheskaia Farmakologiia 65: 57-59.
7. Udintsev SN, Shakhov VP, Borovskoi IG (1991): Mechanism of differential effect of low dose adaptogens on the functional activity of normal and transformed cellular elements in vitro. Biofizika 36: 624-627.
8. Udintsev SN, Shakhov VP (1990): Changes in clonogenic properties of bone marrow and transplantable mice tumor cells during combined use of cyclophosphane and biological response modifiers of adaptogenic origin. Eksp Onkol 12: 55-56.
9. Min BS, Bae KH, Kim YH (1999): Screening of Korean plants against human immunodeficiency virus type 1 protease. Phytother Res 13: 680-682.
10. Razina TG, Zueva EP, Amosova EN, Krylova SG (2000): Medicinal plant preparations used as adjuvant therapeutics in experimental oncology. Ekspe Klin Farmakol 63: 59-61.
11. Furmanowa M, Hartwich M, Alfermann AW et al. (1999): Rosavin as a product of glycosylation by Rhodiola rosea (roseroot) cell cultures. Plant Cell Tissue and Organ Culture 56: 105-110.
12. Hartwich M. Production of selected phenolic glycosides of Rhodiola rosea using biotechnological methods. Ph.D. Thesis. Warsaw Medical Academy. Warsaw 1999.
13. Tolonen A, György Z, Jalonen J et al. (2004): LC/MS/MS identification of glycosides produced by biotransformation of cinnamyl alcohol in Rhodiola rosea compact callus aggregates. Biomed Chromatogr 18: 550-558.
14. Shin DS, Kim JH, Lee SK et al. (2006): Synthesis and biological evaluation of dimeric cinnamaldehydes as potent antitumor agents. Bioorg Med Chem 14: 2498-2506.
15. Kurkin VA, Zapesochnaya GG, Shchavlinskii AN et al. Rosavin. Patent written in Russian. All-Union Scientific-Research Institute of Medicinal and Aromatic Plants, USSR. U.S.S.R. (1985), CODEN: URXXAF SU 1168254 A1 19850723.
16. Kishida M, Akita H (2005): Synthesis of Rosavin and its analogs based on a Mizoroki-Heck type reaction. Tetrahedron. Asymmetry 16: 2625-2630.
17. Patov SA, Punegov VV, Kuchin AV (2006): Synthesis of the Rhodiola rosea glycoside rosavin. Chemistry of Natural Compounds 42: 397-399.
18. Dement'eva LA, Iaremenko KV (1987): Effect of a Rhodiola extract on the tumor process in an experiment. Vopr Onkol 33: 57-60.
19. Udintsev SN, Shakhov VP (1989): Decrease in the growth rate of Ehrlich's tumor and Pliss' lymphosarcoma with partial hepatectomy. Vopr Onkol 35: 1072-1075.
20. Udintsev SN, Shakhov VP (1991): The role of humoral factors of regenerating liver in the development of experimental tumors and the effect of Rhodiola rosea extract on this process. Neoplasma 38: 323-331.
21. Bocharova OA, Serebriakova RV, Bodrova NB (1994): Preventive effect of Rhodiolae rosea in spontaneous liver carcinogenesis in a mice model of high-tumor strain. Vestn Ross Akad Med Nauk 5: 41-43.
22. Baltina L A, Serdyuk NG (1994): Cytostatic action of medicinal plants on cultured lymphoblastoids. Khimiko-Farmatsevticheskii Zhurnal 28: 49-51.
23. Kormosh N, Laktionov K, Antoshechkina M (2006): Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res 20: 424-425.
24. Majewska A, Hoser G, Furmanowa M et al. (2006): Antiproliferative and antimitotic effect, S phase accumulation and induction of apoptosis and necrosis after treatment of extract from Rhodiola rosea rhizomes on HL-60 cells. J Ethnopharmacol 103: 43-52.
25. Zapesochnaya GG, Kurkin V A, Boiko VP (1995): Phenylpropanoids as prospective bioactive substances from medicinal plants. Khimiko- Farmatsevticheskii Zhurnal 29: 47-50.
26. Sokolov SY, Boiko VP, Kurkin VA et al. (1990): Comparative examination of stimulant properties of some phenylpropanoids. Khimiko-Farmatsevticheskii Zhurnal 24: 66-68.
27. Kurkin VA, Dubishchev AV, Ezhkov VN et al. (2006): Antidepressant activity of some phytopharmaceuticals and phenylpropanoids. Pharmaceutical Chemistry Journal 40: 614-619.
28. Kurkin VA, Dubishchev AV, Ezhkov VH et al. (2007): Nootropic activity of some phytopreparations and phenylpropanoids. Rastitel'nye Resursy 43: 76-88.
29. Skopińska-Różewska E, Mścisz A, Sommer E et al. (2005): The influence of different Rhodiola extracts on murine tumor cells angiogenic activity. Herba Polonica 51 (Suppl 1): 172.
30. Wiedenfeld H, Dumaa M, Malinowski M, Furmanowa M (2007): Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifida. Pharmazie 62: 308-311.
31. Mielcarek S, Mścisz A, Buchwald W et al. (2005): Phytochemical investigation of Rhodiola sp. root extracts. Herba Polonica 51 (Suppl 1): 159.
32. Siwicki AK, Skopińska-Różewska E, Hartwich M et al. (2007): The influence of Rhodiola rosea extracts on non-specific and specific cellular immunity in pigs, rats and mice. Centr Eur J Immunol 32: 84-91.
33. Skopińska-Różewska E, Skurzak H, Wasiutyński A et al. (2007): Sarcoma L-1 in mice as a model for the study of experimental angiogenesis. Centr Eur J Immunol 32: 77-83.
34. Sidky YA, Auerbach R (1975): Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs-host reaction. J Exp Med 141: 1084-1100.
35. Kamiński MJ, Bem W, Majewski S et al. (1981): Angiogenesis induction by xenogeneic lymphoid and non-lymphoid cells in mice. Arch Immunol Ther Exp (Warsz) 29: 521-523.
36. Skopińska-Różewska E, Sommer E, Demkow U et al. (1997): Screening of angiogenesis inhibitors by modified tumor-induced angiogenesis (TIA) test in lung cancer. Rocz Acad Med Bialyst 42: 287-296.
37. Skopinska-Różewska E, Krotkiewski M, Sommer E et al. (1999): Inhibitory effect of shark liver oil on cutaneous angiogenesis induced in Balb/c mice by syngeneic sarcoma L-1, human urinary bladder and human kidney tumor cells. Oncol Rep 6: 1341-1344.
38. Sommer E, Skopińska-Różewska E, Skurzak H (2001): The effect of linoleic acid on the growth and vascularity of L-1 sarcoma in mice and on the cutaneous angiogenesis induced by tumor cells. Współczesna Onkologia 5: 250-253.
39. Skopińska-Różewska E, Piazza GA, Sommer E et al. (1998): Inhibition of angiogenesis by Sulindac and its sulfone metabolite (FGN-1): A potential mechanism for their antineoplastic properties. Int J Tissue React 20: 85-89.
40. Gil M, Skopińska-Różewska E, Radomska D et al. (1993): Effect of purinergic receptor antagonists Suramin and Theobromine on tumor-induced angiogenesis in Balb/c mice. Folia Biol (Praha) 39: 63-68.
41. Skopińska-Różewska E, Janik P, Przybyszewska M et al. (1998): Inhibitory effect of Theobromine on induction of angiogenesis and VEGF mRNA expression in v-raf transfectants of human urothelial cells HCV-29. Int J Mol Med 2: 649-652.
42. Barcz E, Sommer E, Janik P et al. (2000): Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells. Oncol Rep 7: 1285-1291.
43. Wasiutyński A, Skopińska-Różewska E, Jung L et al. (2006): Comparison of the effects of Enoxaparin and Nadroparin on tumor angiogenesis in mice. Centr Eur. J Immunol 31: 70-74.
44. Skopinski P, Szaflik J, Duda-Król B et al. (2004): Suppression of angiogenic activity of sera from diabetic patients with nonproliferative retinopathy by compounds of herbal origin and sulindac sulfone. Int J Mol Med 14: 707-711.
45. Siwicki AK, Skopińska-Różewska E, Nartowska J et al. (2004): Effect of Immunostim Plus - a standarized fixed combination of Schizandra chinensis with Eleutherococcus senticosus extracts on granulocyte activity and tumor angiogenesis in mice. Bull Vet Inst Pulawy 48: 489-492.
46. Bałan BJ, Skopińska-Różewska E, Barcz E et al. (1999): The effect of selected phenolic acids on angiogenic activity of ovarian cancer cells - preliminary report. Onkol Pol 2: 203-208.
47. Skopiński P, Skopińska-Różewska E, Sommer E et al. (2005): The effect of some diet-derived angiogenesis inhibitors and sulindac sulfone on the ability of VEGF, bFGF and IL-18 to induce cutaneous neo-vascular response in mice. Pol J Environ Studies 14 (S II, part I): 325-329.
48. Skopińska-Różewska E, Sommer E, Bałan B et al. (1995): Methyloxantines as angiogenesis inhibitors. Int J Oncol 7 (Suppl 1): 949.
49. Wasiutyński A, Siwicki AK, Bałan BJ et al. (2005): Inhibitory effect of cocoa catechins on embryonic and tumor angiogenesis in mice. Pol J Environ Studies 14(II): 800-805.
50. Nartowska J, Sommer E, Siwicki AK et al. (2005): The anti-angiogenic and immunotropic properties of convallamaroside, a steroidal saponin isolated from rhizomes and roots of Convallaria majalis L. Pol J Environ Studies 14(II): 296-299.
51. Skopińska-Różewska E, Chorostowska-Wynimko J, Krotkiewski M et al. (2003): Inhibitory effect of Greenland Shark Liver Oil combined with Squalen and Arctic birch ashes on angiogenesis and L-1 Sarcoma growth in Balb/c mice. Pol J Vet Sci 6: 54-56.
52. Skopińska-Różewska E, Nartowska J, Wojtasik E et al.: Poszukiwanie inhibitorów angiogenezy nowotworowej wśród leków naturalnych o własnościach immunomodulujaçych. In: Siwicki AK, Skopińska-Różewska E (eds.). Naturalne i syntetyczne modulatory odpowiedzi immunologicznej i angiogenezy, SPW EDYCJA, Olsztyn 2006, 7-26.
53. Bany J, Skopińska-Różewska E, Chorostowska-Wynimko J et al. (2004): The effect of complex herbal remedy on the angiogenic activity of L-1 sarcoma cells, L-1 sarcoma tumor growth, and on the bacterial infection in mice. Centr Eur J Immunol 29: 29-34.
54. Jeong HW, Han DC, Son KH et al. (2003): Antitumor effect of the cinnamaldehyde derivative CB403 through the arrest of cell cycle progression in the G2/M phase. Biochem Pharmacol 65: 1343-1350.
55. Sui XL, Yang F, Chen RH et al. (2006): Inhibition of Rhodiola on the growth of EVC-304 cell line. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 22: 524-525.
56. Skopińska-Różewska E, Malinowski M, Wasiutyński A et al. (2008): The influence of Rhodiola quadrifida 50% alcoholic extract and salidroside on tumor-induced angiogenesis in mice. Pol J Vet Sci (in press).